Louis Moore Bacon's FOLD Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 137,000 shares of Amicus Therapeutics, Inc. (FOLD) worth $1.95 M, representing 0.03% of the portfolio. First purchased in 2014-Q4, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Louis Moore Bacon has maintained a strategic position in FOLD, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 137,000 shares. Largest reduction occurred in Q3 2015, reducing 150,000 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Amicus Therapeutics (FOLD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amicus Therapeutics (FOLD) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +137,000 | New Buy | 137,000 | $14.24 |
| Q4 2017 | -100,000 | Sold Out | 0 | $0.00 |
| Q3 2017 | +100,000 | New Buy | 100,000 | $15.08 |
| Q1 2016 | -125,000 | Sold Out | 0 | $0.00 |
| Q3 2015 | -150,000 | Reduce 54.55% | 125,000 | $13.99 |
| Q2 2015 | +134,359 | Add 95.53% | 275,000 | $14.15 |
| Q1 2015 | -84,359 | Reduce 37.49% | 140,641 | $10.88 |
| Q4 2014 | +225,000 | New Buy | 225,000 | $8.32 |
Louis Moore Bacon's Amicus Therapeutics Investment FAQs
Louis Moore Bacon first purchased Amicus Therapeutics, Inc. (FOLD) in Q4 2014, acquiring 225,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Amicus Therapeutics, Inc. (FOLD) for 9 quarters since Q4 2014.
Louis Moore Bacon's largest addition to Amicus Therapeutics, Inc. (FOLD) was in Q4 2014, adding 225,000 shares worth $1.87 M.
According to the latest 13F filing for Q4 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 137,000 shares of Amicus Therapeutics, Inc. (FOLD), valued at approximately $1.95 M.
As of the Q4 2025 filing, Amicus Therapeutics, Inc. (FOLD) represents approximately 0.03% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in Amicus Therapeutics, Inc. (FOLD) was 275,000 shares, as reported at the end of Q2 2015.